Should You Invest in Incyte Corp. (INCY) Now?

Incyte Corp. (NASDAQ: INCY) has a higher price-to-earnings ratio of 21.11x compared to its average ratio, The 36-month beta value for INCY is at 0.67. Analysts have varying views on the stock, with 12 analysts rating it as a “buy,” 5 rating it as “overweight,” 4 as “hold,” and 0 as “sell.”

The public float for INCY is 221.84M, and currently, shorts hold a 3.56% of that float. The average trading volume for INCY on April 03, 2024 was 1.73M shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

INCY) stock’s latest price update

The stock price of Incyte Corp. (NASDAQ: INCY) has plunged by -1.43 when compared to previous closing price of 56.64, but the company has seen a -2.87% decline in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-03-14 that Incyte (INCY) reported earnings 30 days ago. What’s next for the stock?

INCY’s Market Performance

INCY’s stock has fallen by -2.87% in the past week, with a monthly drop of -5.45% and a quarterly drop of -11.08%. The volatility ratio for the week is 1.78% while the volatility levels for the last 30 days are 2.23% for Incyte Corp. The simple moving average for the past 20 days is -4.26% for INCY’s stock, with a -6.93% simple moving average for the past 200 days.

Analysts’ Opinion of INCY

Many brokerage firms have already submitted their reports for INCY stocks, with Jefferies repeating the rating for INCY by listing it as a “Buy.” The predicted price for INCY in the upcoming period, according to Jefferies is $81 based on the research report published on February 23, 2024 of the current year 2024.

Leerink Partners gave a rating of “Outperform” to INCY, setting the target price at $78 in the report published on December 13th of the previous year.

INCY Trading at -5.41% from the 50-Day Moving Average

After a stumble in the market that brought INCY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.58% of loss for the given period.

Volatility was left at 2.23%, however, over the last 30 days, the volatility rate increased by 1.78%, as shares sank -6.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.20% lower at present.

During the last 5 trading sessions, INCY fell by -2.87%, which changed the moving average for the period of 200-days by -9.13% in comparison to the 20-day moving average, which settled at $58.12. In addition, Incyte Corp. saw -11.08% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at INCY starting from Stein Steven H, who sale 7,365 shares at the price of $65.51 back on Jan 03 ’24. After this action, Stein Steven H now owns 90,218 shares of Incyte Corp., valued at $482,481 using the latest closing price.

Iyengar Vijay K, the EVP, GMAPPS of Incyte Corp., sale 657 shares at $65.00 during a trade that took place back on Jan 02 ’24, which means that Iyengar Vijay K is holding 43,412 shares at $42,705 based on the most recent closing price.

Stock Fundamentals for INCY

Current profitability levels for the company are sitting at:

  • 0.19 for the present operating margin
  • 0.93 for the gross margin

The net margin for Incyte Corp. stands at 0.16. The total capital return value is set at 0.12. Equity return is now at value 12.50, with 9.41 for asset returns.

Based on Incyte Corp. (INCY), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 12.97. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 269.0.

Currently, EBITDA for the company is 904.74 million with net debt to EBITDA at -3.67. When we switch over and look at the enterprise to sales, we see a ratio of 2.53. The receivables turnover for the company is 4.97for trailing twelve months and the total asset turnover is 0.54. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.75.

Conclusion

In conclusion, Incyte Corp. (INCY) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts